Linda Fried
Showing 1–5 of 5 transcripts.
- Milken Institute1h 13m
Getting Our Health Priorities in Order: Prevention, Research, and Treatment
Ed Greissing, Katie Couric, Mark Alles, Tom Beauregard, Linda Fried, Eric Lefkofsky, Jim Robinson
Addressing a critical misalignment where preventive social factors drive 70% of health outcomes despite comprising only 5% of spending, industry leaders from UnitedHealth, Celgene, and Tempus are pivoting toward virtual prevention and genomic data integration. Innovations such as Project Not Me, early-stage biological interception, and million-fold reductions in sequencing costs aim to overcome regulatory friction and treat diseases before they manifest, as demonstrated by UnitedHealth's prenatal care model that reduced preterm births by 30%. The panel concludes that immediate progress requires interoperable data platforms to replace siloed systems, enabling the digital infrastructure necessary to close the nine-year life expectancy gap driven by socioeconomic disparities.
- Milken Institute59 min
The Influencers: How Increasing Longevity Will Shape Our World
Paula Kerger, Marc Freedman, Linda Fried, Ai-jen Poo, Nora Super
A panel of experts addresses the critical demographic shift toward an aging population, highlighting the economic potential of a 25-million-strong "second act" workforce and the systemic gaps in caregiving infrastructure. The discussion contrasts outdated retirement models with emerging intergenerational strategies, such as formalized "gap years" for older adults and technological integration in home care, while noting the urgency of reforming Medicare and Social Security to sustain these changes. By framing longevity as a collective national opportunity rather than a burden, the session urges policymakers to adopt new life-stage categories and invest equally in the quality of extended lives alongside longevity itself.
- Milken Institute1h 18m
Public Health, Medical Research and the Cancer Moonshot: A Collaboration to Change the World
Michael Milken, Francis Collins, Linda Fried, Robert Hugin, Freda Lewis-Hall
Vice President Biden and medical leaders are launching a strategic "Cancer Moonshot" to overcome siloed research through a $680 million federal investment and the Precision Medicine Initiative's enrollment of one million Americans. The framework prioritizes seven key themes, including early detection blood tests, single-cell analysis, and public-private partnerships modeled after the Accelerating Medicines Partnership, while explicitly warning against overpromising a timeline for a universal cure. Parallel to the National Institutes of Health and FDA funding, the initiative integrates public health science to address prevention drivers and leverages global data collaboration to accelerate the shift toward data-driven, individualized cancer therapies.
- Milken Institute46 min
A Future of Healthy Aging
Paul Irving, Pinchas Cohen, Linda Fried, Freda Lewis-Hall, Robin Mockenhaupt
A global panel convened to address the critical misalignment between rising life expectancy and stagnant healthspan, framing older adults as an underutilized human capital asset essential for the 21st-century economy. The discussion highlighted that delaying Alzheimer's onset by five years could halve annual caregiving costs and proposed a "Frieden's Triangle" strategy combining genomic risk assessment, social engagement programs, and targeted public health policies to transform prevention. To realize this vision, the group advocated for a "third demographic dividend" through a tenfold increase in federal funding, clinical trial reforms for geriatric populations, and the creation of new social institutions designed specifically for the emerging thirty-year life stage.
- Milken Institute1h 1m
The Business Case for Wellness: Is a Wellness Dollar Worth More than a Treatment Dollar?
Linda Fried, Nancy Brown, Bill Dietz, Steve Bird, Andy
A multi-sector panel of healthcare leaders and corporate executives argues that shifting resources from treatment to prevention is now a viable, high-ROI business model capable of reducing US healthcare costs by 40–50%. Successful implementation relies on collaborative strategies between governments, corporations like Safeway, and individuals to address environmental drivers of disease while leveraging technology for personal accountability. Despite persistent socioeconomic disparities and small business constraints, experts agree that aligning financial incentives across payers and providers will create a necessary "culture of health" to reverse the US health paradox within the next decade.